Accelerating Generic Drug Approvals Will Save Lives and Dollars
By Peter J. Pitts
Sitting atop the approval process for prescription medications, Dr. Scott Gottlieb is a little different from some of his more bureaucratic predecessors: He's listening.
Last month, the commissioner of the Food and Drug Administration hosted a public meeting to solicit input from patients, care providers, and drug makers on how to improve the FDA's drug approval process and, just as importantly, expedite the introduction of generic drugs.
Far too often in Washington, regulators approach their mission by dictating terms to those in their purview. Gottlieb is different: His starting point is how the FDA can most efficiently get safe and effective treatments to the patients who need them. Improving the FDA's processes can drive healthcare costs down dramatically and save millions of lives.
Take generics: Between 2005 and 2014, generics generated about $1.7 trillion in healthcare savings in America.
They also pressure rival products to lower their prices. One FDA study found that when a brand-name drug has eight generic competitors, patients buying the generic versions pay on average just 20 percent of the cost of the brand name. When a drug has only four generic versions, patients pay twice as much -- 40 percent of the brand-name price.
And with only one generic competitor, generic buyers will see a minimal discount, paying on average 94 percent of the price of the brand-name. So in Gottlieb's view, the more the better.
But speeding up generic approvals will be a challenge. The existing FDA channels are notoriously slow, gummed up with antiquated procedures. It's been 30 years since the federal law governing generics has been significantly updated. The rules are especially unclear for complex generic drugs using delivery mechanisms that were invented only in the past few years.
This uncertainty lengthens the time it takes for a generic drug to win approval. The FDA is now staring down a backlog of 2,600 pending applications. Today, getting a new generic approved costs about $5 million and takes four years.
With delayed approval of generics, brand name drugs face less competition. For all too many drugs whose patents have expired, few companies if any have stepped up to create rival generic products. For about 10 percent of off-patent drugs, the FDA has received not a single generic application.
Without competition from other drug makers, manufacturers can charge monopoly-level prices even for decades-old medications. That's exactly what happened with the price hike that brought "Pharma Bro" Martin Shkreli to national notoriety. Shkreli's firm acquired the rights to produce the infection medication Daraprim -- then immediately jacked up the price from $13 to $750. That hike only was possible because Daraprim had no real generic competition.
Commissioner Gottlieb has made ending the needless delays his top priority. His team has already started clearing out the application backlog and has announced plans to provide faster consideration for applications for drugs for which there are fewer than three firms currently making generics.
The FDA will also publish a list of off-patent drugs for which no company has applied to produce a generic version. The agency hopes that collecting that information and publicizing it will attract competitors into the market and also reduce the potential for life-threatening drug shortages.
Gottlieb is tackling a tough and urgent public health issue head on. And Congress is helping -- specifically through reauthorizing the Prescription Drug User Fee Act (PDUFA), a breakthrough 1992 piece of federal legislation that requires drug companies to pay fees to cover the cost of the review and approval of their products.
Back in the early 90s, the FDA was drowning in drug applications. It didn't have enough money or staff to review and approve medications in the pipeline. So Congress passed PDUFA to shore up the agency's financing and expedite reviews. The bill worked. The average drug approval time fell from two and half years to just under 11 months. PDUFA has since helped usher 1,500 new drugs to market.
Re-authorizing PDUFA will give Gottlieb the resources he needs to make these reforms a reality. A life- and cost-saving revolution is now underway at the FDA.
Peter J. Pitts, a former FDA associate commissioner, is president of the Center for Medicine in the Public Interest.
More Resources
Unable to open RSS Feed $XMLfilename with error HTTP ERROR: 404, exitingMore Medicine Information:
Related Articles
Over The Counter Pain Medication: How To Choose The Right Drugs
With the recent front-page news about the possible hazards of pain medications, you may be taking a look at your over-the-counter (or OTC) pain medications with a wary eye. While all drugs, including those you don't need a prescription for, can be dangerous, some basic knowledge can help you avoid the pitfalls for the pain relief you need.
Hidden ER Costs Undermine Health Markets
Imagine you're traveling in a different state when, suddenly, you begin to feel severe abdominal pain. Being unfamiliar with the area and wanting to avoid hefty out-of-network bills, you call your insurance company to find an in-network hospital.
Benign Tumors Of The Cervix
Endocervical polypsEndocervical polyps are the most common benign neoplasms of the cervix. Please note that the word neoplasm refers to a cancerous growth.
Top Five FAQs About Nail Fungus
What is nail fungus?Nail fungus, also known as Onychomycosis, is an organism which digests the keratin found in your fingernails and toenails. The fingernail and toenail are naturally built to be strong barriers, and resistant to fungi and other infections.
Medical Tourism Opportunities in India
More and more people have started travelling to India for Medical Treatment and during the past year alone, over 150000 people travelled to India for their medical requirements. Medical Tourism is finally coming of age.
The Truth about C Reactive Protein and Cholesterol Lowering Drugs
You might disagree, but hear me out on this..
A Compelling Look at Pain Relief
If your back aches when you're loading groceries in the car or your hands cramp up with arthritis when you sit down at the computer, you're not alone. Although the nature, cause, and complaints vary, over one-half of Americans experience chronic or recurrent pain, a recent survey conducted by the Stanford University Medical Center found.
Toenail Fungus: Treatment and Prevention
A thick, yellowish nail with splotchy white areas is a classic presentation for a fungal toenail. In the early stages the toenail is only slightly discolored, or slightly thickened.
Traditional Treatments for Back Pain... Which Ones Work and Which Ones Don't?
When Dorothy followed the yellow brick road, she was told to do so by those who wanted her to get where she wanted go. Well as humans when we blindly follow recommendations even by individuals who have good intentions, it may not always be your best option.
Bee Propolis: Synergisitc Health Care for the 21st Centruy
For well over a century modern science has progressed at a startling rate. With this increase in knowledge has come medicinal and healthcare benefits that have seen ages peak and diseases eradicated.
Mind Altering
"It's a chemical imbalance." I've heard those words so many times in the last decade, it's becoming routine for Doctors to blame everything on it.
Kids and Medication Part I
We have all talked a lot about the problems in our educational system, about latchkey kids, about teacher turnover (50 percent of teachers quitted within the first five years on the job), psychologists over prescribing medications such as Prozac and Ritalin with our friends and families. We can all foresee a terrible problem in the future because we are feeding these drugs to kids under the age of six, their brains have not been fully formed yet and these drugs and their predecessors and competing drugs all have adverse side effects.
Serevent Side Effects Put Serevent in Top 5 Most Dangerous Drugs
Serevent is an asthma inhalation medication, a bronchodilator, that relaxes the muscles in airways. It is preventative and not effective when taken during an asthma attack.
The Power of Ice
Using ice to treat injuries is one of the oldest methods of pain control. Proven to be safe and effective at reducing swelling, relieving pain and decreasing muscle spasms, ice therapy is an easy self-care technique that anyone can administer.
What Not to Tell Your Doctor?
For many years since medicine has been established as anethical profession and gained widespread credence peoplehave believed that they could and should tell their doctoreverything even remotely pertinent to their health and thatit was held in the strictest confidence. Furthermore, howcan the physician make accurate judgments when important orsignificant information is missing? This system worked verywell until relatively recently but there now exists a breachof this confidence that people should know about and thisbreach has developed from the advent of third partyinvestigations into people's backgrounds.
Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers
Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck's Vioxx and Pfizer's Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently.
Protopic Cancer Risk Lawyer
The FDA issued a warning in July of 2005 on two skin creams, Elidel (pimecrolimus) and Protopic (tacrolimus) to all ages. Recent animal studies have found that Protopic causes lymphomas and skin cancers in an unknown percentage of users.
Melatonin, Sleep Enhancement, and ADHD
OverviewMelatonin is a natural hormone, which is produced and secreted by the pineal gland. Melatonin plays an important role in the regulation of many hormones in the body.
Bulk Forming Drugstore Laxatives
There are five basic types of drugstore laxatives you should be aware of. Some of these laxatives can be dangerous to use.
Sinusitis: Sinus Infection Deals a Corporate KO
Sinusitis and Sinus Infection Starts with a Little SniffleYes, I hear it too. A simple sniffle in a distant cubical.
Cetyl Myristoleate for Arthrtis: Science or Speculation
There are a lot of fabulous stories about Cetyl Myristoleate (also known as CMO or CM) floating across the Internet. Mine is one of them.